Cargando…
Nicotinamide breaks effector CD8 T cell responses by targeting mTOR signaling
Nicotinamide (NAM) shapes T cell responses but its precise molecular mechanism of action remains elusive. Here, we show that NAM impairs naive T cell effector transition but also effector T cells themselves. Although aerobic glycolysis is a hallmark of activated T cells, CD8(+) T cells exposed to NA...
Autores principales: | Agliano, Federica, Karginov, Timofey A., Ménoret, Antoine, Provatas, Anthony, Vella, Anthony T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886054/ https://www.ncbi.nlm.nih.gov/pubmed/35243268 http://dx.doi.org/10.1016/j.isci.2022.103932 |
Ejemplares similares
-
Optimal CD8(+) T cell effector function requires costimulation-induced RNA-binding proteins that reprogram the transcript isoform landscape
por: Karginov, Timofey A., et al.
Publicado: (2022) -
Evaluating the glycolytic potential of mouse costimulated effector CD8(+) T cells ex vivo
por: Agliano, Federica, et al.
Publicado: (2022) -
Antigen-specific downregulation of miR-150 in CD4 T cells promotes cell survival
por: Ménoret, Antoine, et al.
Publicado: (2023) -
A benzimidazole inhibitor attenuates sterile inflammation induced in a model of systemic autoinflammation in female mice
por: Agliano, Federica, et al.
Publicado: (2020) -
mTOR-dependent translation drives tumor infiltrating CD8(+) effector and CD4(+) Treg cells expansion
por: De Ponte Conti, Benedetta, et al.
Publicado: (2021)